ALENTIS THERAPEUTICS TO PARTICIPATE IN THE ASCO ANNUAL MEETING AND BIO INTERNATIONAL CONVENTION Post published:May 31, 2023 Continue ReadingALENTIS THERAPEUTICS TO PARTICIPATE IN THE ASCO ANNUAL MEETING AND BIO INTERNATIONAL CONVENTION
ALENTIS THERAPEUTICS AWARDED CHF 2.4M SWISS ACCELERATOR GRANT BY INNOSUISSE Post published:May 9, 2023 Continue ReadingALENTIS THERAPEUTICS AWARDED CHF 2.4M SWISS ACCELERATOR GRANT BY INNOSUISSE
ALENTIS THERAPEUTICS REPORTS POSITIVE TOPLINE RESULTS FROM PHASE 1 MULTIPLE-ASCENDING DOSE COHORTS STUDY Post published:April 26, 2023 Continue ReadingALENTIS THERAPEUTICS REPORTS POSITIVE TOPLINE RESULTS FROM PHASE 1 MULTIPLE-ASCENDING DOSE COHORTS STUDY
ALENTIS TO PRESENT DATA AT AACR Post published:April 14, 2023 Continue ReadingALENTIS TO PRESENT DATA AT AACR
ALENTIS THERAPEUTICS CLOSES $105 MILLION SERIES C FUNDING TO ADVANCE TRANSFORMATIONAL MEDICINES FOR CLAUDIN-1 Post published:April 13, 2023 Continue ReadingALENTIS THERAPEUTICS CLOSES $105 MILLION SERIES C FUNDING TO ADVANCE TRANSFORMATIONAL MEDICINES FOR CLAUDIN-1
ALENTIS THERAPEUTICS makes key leadership appointments Post published:February 17, 2023 Continue ReadingALENTIS THERAPEUTICS makes key leadership appointments
Positive Results from Single Ascending Dose Phase 1 Study of ALE.F02 Targeting Claudin-1 Post published:January 9, 2023 Continue ReadingPositive Results from Single Ascending Dose Phase 1 Study of ALE.F02 Targeting Claudin-1
Alentis Therapeutics Appoints Dr. Luigi Manenti as Chief Medical Officer Post published:January 5, 2023 Continue ReadingAlentis Therapeutics Appoints Dr. Luigi Manenti as Chief Medical Officer
Preclinical data published in Science Translational Medicine provide proof-of-concept for Claudin-1-specific monoclonal antibodies for the treatment of fibrosis and cancer prevention across organs Post published:December 21, 2022 Continue ReadingPreclinical data published in Science Translational Medicine provide proof-of-concept for Claudin-1-specific monoclonal antibodies for the treatment of fibrosis and cancer prevention across organs